cardiovascular events
In the CIBIS trial, they are those patients with the lower left       ventricular ejection fractions and those who have nonlethal cardiovascular events       but in whom beta-blocker therapy is not permanently discontinued.
In the CIBIS trial, they are those  @OBJECT$  with the lower left       ventricular ejection fractions and those who  @PREDICAT$  nonlethal  @SUBJECT$        but in whom beta-blocker therapy is not permanently discontinued.